News
08-30-2016, 06:40 AM
Previous studies at the University of Colorado Cancer Center show that the experimental drug AMPI-109 potently kills triple-negative breast cancer cells.
More... (http://www.news-medical.net/news/20160830/Experimental-drug-may-become-key-tool-to-target-triple-negative-breast-cancer-with-immunotherapy.aspx)
More... (http://www.news-medical.net/news/20160830/Experimental-drug-may-become-key-tool-to-target-triple-negative-breast-cancer-with-immunotherapy.aspx)